SHM Converge Meeting News Central
  • hospitalmedicine.org
  • #SHMConverge25
  • Daily Coverage
  • Awards
  • Special Events
  • Program
  • Previews
Topics
  • Daily Coverage
  • Awards
  • Special Events
  • Program
  • Previews
Resources
  • Featured Speakers
  • Advanced Learning Courses
  • Conference FAQs
  • Claiming CME and Other Credits
  • SHM Converge 2026
Twitter X icon Facebook iconInstagram iconLinkedIn icon
Apr 8th, 2022

In it for the long haul

Research continues for Post-Acute Sequelae of Covid-19.


William Michael Brode, MD
William Michael Brode, MD

It goes by many names — Post-Acute Sequelae of COVID-19 (PASC), long-COVID, post-COVID syndrome, post-COVID, and chronic COVID-19, to name a few. But regardless of the vernacular, patients who increasingly dub themselves COVID “long-haulers” often come to physicians expecting answers.

William Michael Brode, MD, a general internist and assistant professor of medicine at The University of Texas at Austin, will present on Sunday a range of research dedicated to breaking down what the National Institutes of Health officially terms PASC.

In general, we can think of PASC as the presence of either continuing or completely new COVID-19 symptoms 12 weeks or longer after the first symptoms were detected. Beyond that, Dr. Brode said it’s a bit harder to pin down.

“What is hard about this is that there’s really no consensus diagnostic criteria, let alone a test, and that becomes a problem in the reporting,” Dr. Brode said. His take on the NIH definition is that it captures the scale and scope of the illness but is so broad that it’s clinically useless. “If it quacks like a duck, then maybe, just possibly, ducks exist,” he joked.

But there’s nothing humorous about the patients who are looking for answers.

“My approach in our program to all patients is, first of all, I believe them,” he said. “I think we should just show some humility. Doctors, when faced with the unknown, tend to downplay symptoms or say it’s all in your head, and I’ve met plenty of people who are high functioning and have unexplained symptoms.”

PASC is disproportionately affecting women and people of color, two groups which Dr. Brode said tend to have their concerns downplayed by physicians. The vast range of post-acute sequelae doesn’t help matters, either.

“The most common symptoms are fatigue, post-exertional malaise, neurocognitive impairment (brain fog), anxiety, shortness of breath, and palpitations,” he said. “On our intake surveys, the patients endorse a median of 19 symptoms, though.”

Research papers have suggested 33 different clinical phenotypes of long-COVID, but Dr. Brode identifies and plans to discuss what he calls three “flavors” of these phenotypes that he sees in his clinic:

  • Post-ICU syndrome with end organ damage from critical disease
  • Persistent symptoms including cough in people who have moderate to severe illness (whether hospitalized or not)
  • Young people, predominantly women, who have new onset dysfunction of the autonomic nervous system.

“All of these groups have severe fatigue, post-exertional malaise and ‘brain fog,’ but will usually have other features,” he says.

And who’s at risk for developing PASC?

“This is tough, once again. Most papers are saying the greater the initial severity, the sicker you were, the more the symptoms persist. That makes sense,” Dr. Brode said. “And I think the question people always ask me is, ‘What is the risk of developing post-COVID or long-COVID after a breakthrough infection for those who are vaccinated?’ The vaccine — the good news is it really protects for all of these, especially initial illness severity, but there definitely are in some studies reports of breakthrough infections developing PASC, and so we don’t’ know the exact measurement. I think that’s being actively studied too, but I can say the risk is less with vaccine, but it is not zero, unfortunately.”  

Visit SHM Meeting News Central for more coverage.

Interesting Stories
SHM Hill Day 2024: Working for you on Capitol Hill
From SHM
SHM Hill Day 2024: Working for you on Capitol Hill
Shining a Spotlight on National Hospitalist Day
From SHM
Shining a Spotlight on National Hospitalist Day
JHM’s Innovations Corner and Point Counterpoint
From SHM
JHM’s Innovations Corner and Point Counterpoint
More Content
Nashville At Night
SHM Converge Meeting News Central
Mark your calendar for SHM Converge 2026
May 7th, 2025
Shm Converge Crowd Shot
Daily Coverage
SHM Converge 2025 Las Vegas delivers
May 7th, 2025
Alfred Burger, MD, MS, SFHM
SHM Converge Meeting News Central
What have we learned?
May 7th, 2025
Dustin Smith, MD, SFHM, and Joanna Bonsall, MD, PhD
Daily Coverage
High-rolling research
Apr 25th, 2025
Day3 Featured
Daily Coverage
Converge Chit Chat | Take-home learning
Apr 25th, 2025
Thomas D. Selby, MD
Daily Coverage
Recognizing skin emergencies
Apr 25th, 2025
Andrew Dunn, MD
Daily Coverage
Got questions about anticoagulation and thrombosis?
Apr 25th, 2025
Vineet Arora, MD, MAPP
Daily Coverage
The learning never stops for the hospitalist
Apr 25th, 2025
1000003866
Daily Coverage
Converge Chit Chat | Looking forward
Apr 24th, 2025
Top row (left to right): Rachel E. Thompson, MD, MPH, MHM, and Jennifer S. Myers, MD, MHM. Bottom row (left to right): Sunil Kripalani, MD, MSc, MHM, and Guilherme B. Barcellos, MD, MHM.
Daily Coverage
Meet the Elite
Apr 24th, 2025
Smita Kalra, MD, SFHM, FACP (left), and Hollis Ray, MD, DFPM, SFHM
Daily Coverage
The hospitalist’s role in perioperative care
Apr 24th, 2025
Daniel Brotman, MD, FACP, MHM (left), and Leonard Feldman, MD, FACP, FAAP, MHM
Daily Coverage
And the answer is?
Apr 24th, 2025
SHM Converge Meeting News Central
Twitter X icon Facebook iconInstagram iconLinkedIn icon

Society of Hospital Medicine
1500 Spring Garden, Suite 501
Philadelphia, PA 19130

Phone: 800-843-3360
Fax: 267-702-2690
[email protected]